| Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors J Strosberg, G El-Haddad, E Wolin, A Hendifar, J Yao, B Chasen, E Mittra, ... New England Journal of Medicine 376 (2), 125-135, 2017 | 2913 | 2017 |
| Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study JC Yao, N Fazio, S Singh, R Buzzoni, C Carnaghi, E Wolin, J Tomasek, ... The Lancet 387 (10022), 968-977, 2016 | 1182 | 2016 |
| First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas JR Strosberg, RL Fine, J Choi, A Nasir, D Coppola, DT Chen, J Helm, ... Cancer 117 (2), 268-275, 2011 | 852 | 2011 |
| Consensus guidelines for the management and treatment of neuroendocrine tumors PL Kunz, D Reidy-Lagunes, LB Anthony, EM Bertino, K Brendtro, JA Chan, ... Pancreas 42 (4), 557-577, 2013 | 652 | 2013 |
| Gastroenteropancreatic neuroendocrine tumors M Cives, JR Strosberg CA: a cancer journal for clinicians 68 (6), 471-487, 2018 | 528 | 2018 |
| Neuroendocrine tumors, version 1.2015 MH Kulke, MH Shah, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 13 (1), 78-108, 2015 | 412 | 2015 |
| Gastroenteropancreatic high‐grade neuroendocrine carcinoma H Sorbye, J Strosberg, E Baudin, DS Klimstra, JC Yao Cancer 120 (18), 2814-2823, 2014 | 400 | 2014 |
| The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas JR Strosberg, D Coppola, DS Klimstra, AT Phan, MH Kulke, GA Wiseman, ... Pancreas 39 (6), 799-800, 2010 | 392 | 2010 |
| Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial J Strosberg, E Wolin, B Chasen, M Kulke, D Bushnell, M Caplin, RP Baum, ... Journal of Clinical Oncology 36 (25), 2578-2584, 2018 | 379 | 2018 |
| Neuroendocrine and adrenal tumors, version 2.2021, NCCN clinical practice guidelines in oncology MH Shah, WS Goldner, AB Benson, E Bergsland, LS Blaszkowsky, ... Journal of the National Comprehensive Cancer Network 19 (7), 839-868, 2021 | 364 | 2021 |
| The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society JR Howe, K Cardona, DL Fraker, E Kebebew, BR Untch, YZ Wang, ... Pancreas 46 (6), 715-731, 2017 | 348 | 2017 |
| NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018 MH Shah, WS Goldner, TR Halfdanarson, E Bergsland, JD Berlin, ... Journal of the National Comprehensive Cancer Network 16 (6), 693-702, 2018 | 342 | 2018 |
| The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum LB Anthony, JR Strosberg, DS Klimstra, WJ Maples, TM O'Dorisio, ... Pancreas 39 (6), 767-774, 2010 | 329 | 2010 |
| Consensus on biomarkers for neuroendocrine tumour disease K Oberg, IM Modlin, W De Herder, M Pavel, D Klimstra, A Frilling, DC Metz, ... The Lancet Oncology 16 (9), e435-e446, 2015 | 322 | 2015 |
| A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group … PL Kunz, PJ Catalano, H Nimeiri, GA Fisher, TA Longacre, CJ Suarez, ... Journal of Clinical Oncology 36 (15_suppl), 4004-4004, 2018 | 319* | 2018 |
| The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors JR Strosberg, TR Halfdanarson, AM Bellizzi, JA Chan, JS Dillon, ... Pancreas 46 (6), 707-714, 2017 | 308 | 2017 |
| Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors TA Hope, EK Bergsland, MF Bozkurt, M Graham, AP Heaney, K Herrmann, ... Journal of Nuclear Medicine 59 (1), 66-74, 2018 | 306 | 2018 |
| Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors JR Strosberg, A Cheema, J Weber, G Han, D Coppola, LK Kvols Journal of Clinical Oncology 29 (22), 3044-3049, 2011 | 300 | 2011 |
| 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long … JR Strosberg, ME Caplin, PL Kunz, PB Ruszniewski, L Bodei, A Hendifar, ... The Lancet Oncology 22 (12), 1752-1763, 2021 | 280 | 2021 |
| Neuroendocrine tumors MH Kulke, AB Benson, E Bergsland, JD Berlin, LS Blaszkowsky, MA Choti, ... Journal of the National Comprehensive Cancer Network 10 (6), 724-764, 2012 | 251 | 2012 |
